Dongying Li

Researcher

Last publication 2025 Last refreshed 2026-05-16

faculty

19 h-index 103 pubs 1,189 cited

Biography and Research Information

OverviewAI-generated summary

Dongying Li's research focuses on toxicological studies, with a particular emphasis on drug-induced toxicity and the application of genomics in regulatory toxicology. Li has investigated the characterization of cytochrome P450-overexpressing HepG2 cells for assessing liver toxicity and explored the biochemical features and mutations of key proteins in SARS-CoV-2 relevant to RNA therapeutics. A recent publication ranked human drugs by the risk of drug-induced cardiotoxicity using FDA labeling. Li's work also extends to the investigation of traditional Chinese medicine, such as Tanreqing, for its effects on Staphylococcus aureus, and combination therapies like Chenodeoxycholic Acid-Amikacin for bacterial eradication. Li has also contributed to frameworks for integrating large language models into regulatory environments for transparency. With 103 total publications and an h-index of 19, Li collaborates with researchers at the National Center for Toxicological Research, including Ting Li and Weida Tong.

Metrics

  • h-index: 19
  • Publications: 103
  • Citations: 1,189

Selected Publications

  • Beyond QSARs: Quantitative Knowledge–Activity Relationships (QKARs) for enhanced drug toxicity prediction (2025)
    1 citation DOI OpenAlex
  • New approach methodologies (NAMs) for drug-induced liver injury (DILI): Where are we now? (2025)
    5 citations DOI OpenAlex
  • DICTrank Is a Reliable Dataset for Cardiotoxicity Prediction Using Machine Learning Methods (2025)
    3 citations DOI OpenAlex
  • A framework enabling LLMs into regulatory environment for transparency and trustworthiness and its application to drug labeling document (2024)
    11 citations DOI OpenAlex
  • DICTrank: The largest reference list of 1318 human drugs ranked by risk of drug-induced cardiotoxicity using FDA labeling (2023)
    32 citations DOI OpenAlex
  • DICTrank: The largest reference list of 1318 human drugs ranked by risk of drug-induced cardiotoxicity using FDA labeling (2023)
    2 citations DOI OpenAlex
  • Applying genomics in regulatory toxicology: a report of the ECETOC workshop on omics threshold on non-adversity (2023)
    16 citations DOI OpenAlex
  • Pharmacological Effects of Ketoconazole in the Treatment of Steroidogenesis Suppression via CYP17A1 Inhibition May Involve MicroRNA Regulation (2023)
    1 citation DOI OpenAlex
  • Epigenetics in drug disposition &amp; drug therapy: symposium report of the 24<sup>th</sup> North American meeting of the International Society for the Study of Xenobiotics (ISSX) (2022)
    4 citations DOI OpenAlex
  • Integrative approaches for studying the role of noncoding RNAs in influencing drug efficacy and toxicity (2022)
    5 citations DOI OpenAlex
  • Characterization of cytochrome P450s (CYP)-overexpressing HepG2 cells for assessing drug and chemical-induced liver toxicity (2021)
    41 citations DOI OpenAlex
  • Biochemical features and mutations of key proteins in SARS-CoV-2 and their impacts on RNA therapeutics (2021)
    36 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

174 Collaborators 62 Institutions 10 Countries

Top Collaborators

Similar Researchers

Based on overlapping research topics